Martin Holland-chaired Rapid Critical Minerals was back in front of fund managers on Tuesday, seeking to raise about $10 ...

Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...

The first is that the US will continue to provide the mainstay of European defence efforts. The latest battle plans have this ...

TSX Venture Exchange grants conditional approval for Matador’s Change of Business (“COB”) to a hybrid “Technology / Investment” issuer, subject to the Company satisfying the TSXV’s requirements and ...